Advanced search
Publication Cover
Biomarkers Volume 18, 2013 - Issue 8
Submit an article Journal homepage
484
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer

Qingfan YangInstitute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin NTHong Kong;State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong Shatin, NTHong Kong;Shenzhen Research Institute, The Chinese University of Hong Kong ShenzhenPeople's Republic of China;Department of Gastroenterology, First Affiliated Hospital, Sun Yat-sen University GuangzhouPeople’s Republic of China
,
Jing GaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute BeijingPeople’s Republic of China
,
Lixia XuInstitute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin NTHong Kong;State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong Shatin, NTHong Kong;Shenzhen Research Institute, The Chinese University of Hong Kong ShenzhenPeople's Republic of China
,
Zhirong ZengDepartment of Gastroenterology, First Affiliated Hospital, Sun Yat-sen University GuangzhouPeople’s Republic of ChinaCorrespondence[email protected]
[email protected]
,
Joseph J. Y. SungInstitute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin NTHong Kong;State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong Shatin, NTHong Kong;Shenzhen Research Institute, The Chinese University of Hong Kong ShenzhenPeople's Republic of China
&
Jun YuInstitute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin NTHong Kong;State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong Shatin, NTHong Kong;Shenzhen Research Institute, The Chinese University of Hong Kong ShenzhenPeople's Republic of ChinaCorrespondence[email protected]
Pages 721-725 | Received 11 Aug 2013, Accepted 07 Oct 2013, Published online: 06 Nov 2013

References

  • Bastian PJ, Palapattu GS, Lin X, et al. (2005). Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 11:4037–43
  • Calcagno DQ, Gigek CO, Chen ES, et al. (2013). DNA and histone methylation in gastric carcinogenesis. World J Gastroenterol 19:1182–92
  • Cheung KF, Lam CN, Wu K, et al. (2012). Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer 118:947–59
  • Chimonidou M, Strati A, Malamos N, et al. (2013a). SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer. Clin Chem 59:270–9
  • Chimonidou M, Tzitzira A, Strati A, et al. (2013b). CST6 promoter methylation in circulating cell-free DNA of breast cancer patients. Clin Biochem 46:235–40
  • Church TR, Wandell M, Lofton-Day C, et al. (2013). Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. [Epub ahead of print]. doi: 10.1136/gutjnl-2012-304149
  • Crew KD, Neugut AI. (2006). Epidemiology of gastric cancer. World J Gastroenterol 12:354–62
  • di Mario F, Cavallaro LG. (2008). Non-invasive tests in gastric diseases. Dig Liver Dis 40:523–30
  • Edge SB, Byrd DR, Compton CC, et al., eds. (2010). AJCC cancer staging manual. 7th ed. New York (NY): Springer, 84–9
  • Ellinger J, Haan K, Heukamp LC, et al. (2008). CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Prostate 68:42–9
  • Gahan PB. (2010). Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. EPMA J 1:503–12
  • Hoque MO, Feng Q, Toure P, et al. (2006). Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 24:4262–9
  • Kneip C, Schmidt B, Seegebarth A, et al. (2011). SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 6:1632–8
  • Kornek G, Depisch D, Temsch EM, et al. (1991). Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 117:493–6
  • Melnikov A, Scholtens D, Godwin A, et al. (2009). Differential methylation profile of ovarian cancer in tissues and plasma. J Mol Diagn 11:60–5
  • Mirza S, Sharma G, Parshad R, et al. (2010). Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients. Clin Biochem 43:380–6
  • Ng EKO, Leung CPH, Shin VY. (2011). Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients. PLoS ONE 6:e22233
  • Sakashita C, Fukuda T, Okabe S, et al. (2002). Cloning and characterization of the human BAZF gene, a homologue of the BCL6 oncogene. Biochem Biophys Res Commun 291:567--73
  • Tóth K, Sipos F, Kalmár A, et al. (2012). Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS ONE 7:e46000
  • Wallner M, Herbst A, Behrens A, et al. (2006). Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res 12:7347–52
  • Wong TS, Kwong DL, Sham JS, et al. (2004). Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res 10:2401–6
  • Xu L, Li X, Chu ES, et al. (2012). Epigenetic inactivation of BCL6B, a novel functional tumor suppressor for gastric cancer, is associated with poor survival. Gut 61:977–85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.